These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


319 related items for PubMed ID: 26858388

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL, Grant GB, Moss WJ, Durrheim DN, Shefer A, Rota PA, Omer SB, Masresha BG, Mulders MN, Hanson M, Linkins RW, Goodson JL.
    Vaccine; 2019 Sep 10; 37(38):5745-5753. PubMed ID: 30898393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT, Lessler J, Metcalf CJ.
    Expert Rev Vaccines; 2013 Aug 10; 12(8):917-32. PubMed ID: 23984961
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ, Orenstein WA.
    Vaccine; 2018 Sep 05; 36(37):5645-5650. PubMed ID: 30041881
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA, Cairns L, Hinman A, Nkowane B, Olivé JM, Reingold AL.
    Vaccine; 2018 Jan 11; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [Abstract] [Full Text] [Related]

  • 15. Global landscape of measles and rubella surveillance.
    Patel MK, Gibson R, Cohen A, Dumolard L, Gacic-Dobo M.
    Vaccine; 2018 Nov 19; 36(48):7385-7392. PubMed ID: 30318167
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC.
    MMWR Recomm Rep; 1997 Jun 13; 46(RR-11):1-20. PubMed ID: 9213745
    [Abstract] [Full Text] [Related]

  • 18. The end of measles and congenital rubella: an achievable dream?
    Adamo G, Sturabotti G, D'Andrea E, Baccolini V, Romano F, Iannazzo S, Marzuillo C, Villari P.
    Ann Ig; 2017 Jun 13; 29(1):1-26. PubMed ID: 28067934
    [Abstract] [Full Text] [Related]

  • 19. Measles and rubella eradication.
    Hinman AR.
    Vaccine; 2018 Jan 02; 36(1):1-3. PubMed ID: 29183733
    [Abstract] [Full Text] [Related]

  • 20. Global measles elimination efforts: the significance of measles elimination in the United States.
    Strebel PM, Henao-Restrepo AM, Hoekstra E, Olive JM, Papania MJ, Cochi SL.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S251-7. PubMed ID: 15106119
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.